Repositioning approved drugs for the treatment of problematic cancers using a screening approach.Published in:PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0171052By:Varbanov, Hristo P.;Kuttler, Fabien;Banfi, Damiano;Turcatti, Gerardo;Dyson, Paul J.Publication type:Article